Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
514.00    -4.00 (-0.77%)
Bid:
512.00
Ask:
514.00
Spread: 2.00 (0.391%)
Market Cap: £295.77m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

31 Jan 2023 07:00

RNS Number : 3306O
Mortgage Advice Bureau (Hldgs) PLC
31 January 2023
 

31 January 2023

Mortgage Advice Bureau (Holdings) plc 

("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1) today issues a trading update for the year ended 31 December 2022, ahead of publishing its final results on Tuesday, 28 March 2023.

The Group increased revenue for the year by 22% to circa £230m, despite the immediately negative impact of September's mini-budget on the mortgage market, with organic revenue growth of 10%. The acquisition of The Fluent Money Group ("Fluent") on 12 July 2022 added £22m of revenue. The Group's adjusted profit before tax for the year ended 31 December 2022 is expected to be in line with expectations.

The total number of Advisers at the year end was up 20% to 2,254(1) (2021: 1,885), including 182 advisers at Fluent, with the average number of mainstream(2) advisers during the year up 21% to 1,988 (2021: 1,649), representing organic growth of 15%. The number of mainstream advisers at the year end increased by 17% to 2,074 (2021: 1,774), with organic growth in mainstream advisers of 7%.

Following a leap in mortgage interest rates, the withdrawal of many mortgage products and a rapid tightening in lenders' underwriting criteria, Q4 saw significantly reduced house purchase and re-financing activity. Buy-to-Let activity was also significantly impacted. As a result of the sharp slowdown in all mortgage activity, most of our AR firms suspended adviser recruitment and reassessed their staffing requirements for 2023. This has resulted in cutbacks in advisers by some firms, particularly due to the significant short-term fall in purchase transactions requiring a mortgage.

After the Chancellor's Autumn Statement, mortgage rates stabilised and then improved a little towards the year end. The number of mortgages available also started to increase and this trend has strengthened into 2023. Although markets expect further rises in the Bank of England base rate, we expect lending conditions will continue to improve throughout 2023.

As anticipated, our congested pipeline of written new business started completing at a faster pace in Q4 due to lower new business levels freeing-up conveyancing capacity to process cases. We also expect this improving trend to continue through 2023. 

Current Trading and Outlook

Current activity levels are below the levels seen this time last year. However, towards the very end of this month there have been early signs of increasing lead volumes and written business across the Group, which we anticipate will build steadily as borrowers gain confidence in a more stable macroeconomic and interest rate environment.

UK Finance estimates that gross new mortgage lending for 2022 was £322bn (2021: £308bn). The Intermediary Mortgage Lenders Association and UK Finance's recent estimates of gross new mortgage lending for 2023 are £265bn and £275bn respectively, representing a 15% to 18% reduction versus 2022.

Although house purchase transactions will be lower this year, overall we expect a second-half weighted recovery. Re-financing opportunities from MAB's client bank are at a record level for 2023. In the wider market, 1.8 million borrowers' current mortgage deals will expire during 2023, providing further opportunity for MAB. It is forecast that Product Transfers will be a higher proportion of re-financing transactions than in prior years. We are ensuring our resources are deployed where our advisers and customers need them most, with lead generation continuing to be a major area of focus.

We expect to see a fall in adviser numbers in our current ARs during Q1 2023 as firms reduce their headcount in line with expected H1 2023 purchase activity. Lower lead levels result in a tightening of adviser numbers and an increased focus on maximising opportunities and productivity. However, we expect adviser numbers in our current ARs to stabilise in Q2 2023 and then build gradually in the second half as business volumes improve. We expect recruitment of new AR firms to be boosted by the quieter market and the tightening regulatory environment.

Despite the more challenging housing and mortgage market outlook for 2023, MAB's long term fundamentals remain very strong. We have taken a proactive and rigorous approach to costs, while progressing with the planned investment in our proposition to ensure the strongest possible recovery and market share growth in 2024 and beyond. Current trading is in line with expectations.

1 Includes a total of 180 advisers at 31 December 2022 who are later life advisers or advisers in directly authorised firms that use MAB's subsidiary, Auxilium, a specialist protection service provider, for protection. For both later life and directly authorised advisers the fees received by MAB represent the net income received by MAB as there are no commission payouts made by MAB.

2 Excludes directly authorised advisers, later life advisers and advisers from associates in the process of being onboarded under MAB's AR arrangements.

Peter Brodnicki, CEO of MAB, commented:

"Despite the uncertain macroeconomic outlook, MAB remains very well positioned to grow its market share strongly again through 2023. In times like these housing transactions are typically postponed, not lost, and the opportunity these conditions generate for new AR recruitment will benefit MAB in the medium term.

"The technology we have developed to help our AR firms optimise lead flow from existing lead sources and clients will help support an H2 recovery, and boost firm and adviser performance in all market conditions. Strong and effective lead flow has a heightened importance in times where purchase activity slows.

"We anticipate a very strong year ahead for re-financing, a slow but steady improvement in consumer confidence and housing transaction levels, combined with an increase in new AR recruitment and the incremental impact of new lead generation initiatives. I am confident that whilst continuing to grow market share this year, MAB will be in a very strong position to regain significant momentum in 2024."

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Joint Broker +44 (0)20 7260 1000

 

Numis Securities Limited

Stephen Westgate / Giles Rolls

Joint Broker:

Peel Hunt LLP

Andrew Buchanan / Mike Burke +44 (0) 20 7418 8900

 

Media Enquiries:

investorrelations@mab.org.uk

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFVFLVIIVIV
Date   Source Headline
17th Feb 20253:29 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSBusiness Update
31st Jan 20253:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSTrading Update
15th Jan 202512:06 pmRNSDirector/PDMR Shareholding
14th Jan 20253:09 pmRNSBlock listing Interim Review
13th Jan 20259:19 amRNSHolding(s) in Company
31st Dec 202411:56 amRNSDirector/PDMR Shareholding
17th Dec 202411:40 amRNSDirectors' Shareholdings and PDMR notification
2nd Dec 202411:40 amRNSDirector/PDMR Shareholding
15th Nov 20249:41 amRNSDirector/PDMR Shareholding
14th Nov 202411:09 amRNSDirector/PDMR Shareholding
13th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20247:00 amRNSNotice of Capital Markets Day
12th Nov 20249:14 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSAppointment of Nominated Adviser and Joint Broker
4th Nov 20249:09 amRNSDirectors' Shareholdings and PDMR notification
28th Oct 20249:43 amRNSNotification of Major Holdings
15th Oct 20242:47 pmRNSDirectors' Shareholdings and PDMR notification
4th Oct 202412:16 pmRNSDirectors' Shareholdings and PDMR Notification
2nd Oct 20245:15 pmRNSNotification of Major Holdings
30th Sep 20244:19 pmRNSDirectors' Shareholdings and PDMR notification
30th Sep 202411:58 amRNSDirectors' Shareholdings and PDMR notification
30th Sep 20249:42 amRNSDirectors' Shareholdings and PDMR notification
25th Sep 20247:00 amRNSDirectors' Shareholdings and PDMR notification
24th Sep 20247:00 amRNSInterim Results
17th Sep 20241:44 pmRNSDirectors' Shareholdings and PDMR notification
17th Sep 20249:16 amRNSNotification of Major Holdings
30th Aug 20245:17 pmRNSDirectors' Shareholdings and PDMR notification
15th Aug 20243:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Jul 20245:35 pmRNSDirectors' Shareholdings and PDMR notification
25th Jul 20247:00 amRNSTrading Update
22nd Jul 20248:02 amRNSDirectors' Shareholdings and PDMR notification
22nd Jul 20247:00 amRNSDirectors' Shareholdings and PDMR notification
12th Jul 20241:19 pmRNSBlock listing Interim Review
1st Jul 20247:00 amRNSDirector/PDMR Shareholding
25th Jun 20241:57 pmRNSNotification of Major Holdings
25th Jun 20247:00 amRNSNotification of Major Holdings
21st Jun 20243:06 pmRNSNotification of Major Holdings
17th Jun 20245:49 pmRNSDirector/PDMR Shareholding
13th Jun 202412:39 pmRNSDirector/PDMR Shareholding and TVR
12th Jun 20244:46 pmRNSNotification of Major Holdings
4th Jun 20244:18 pmRNSNotification of Major Holdings
31st May 202410:36 amRNSDirectors' Shareholdings and PDMR notification
29th May 20247:00 amRNSRelated Party Transaction
28th May 20243:56 pmRNSNotification of Major Holdings
23rd May 20247:00 amRNSResult of AGM
22nd May 20247:00 amRNSAGM Statement
17th May 20243:26 pmRNSNotification of Major Holdings
14th May 20244:37 pmRNSDirectors' Shareholdings and PDMR notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.